# Cloxacillin as Prevention of Double Lumen Infection in Hemodialysis Patients

> **NCT00885300** · NA · COMPLETED · sponsor: **Shiraz University of Medical Sciences** · enrollment: 100 (actual)

## Conditions studied

- Double Lumen Infection
- Hemodialysis

## Interventions

- **DRUG:** cloxacillin
- **DRUG:** heparin

## Key facts

- **NCT ID:** NCT00885300
- **Lead sponsor:** Shiraz University of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-01
- **Primary completion:** 2008-07
- **Final completion:** 2008-09
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2009-04-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00885300

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00885300, "Cloxacillin as Prevention of Double Lumen Infection in Hemodialysis Patients". Retrieved via AI Analytics 2026-09-26 from https://api.ai-analytics.org/clinical/NCT00885300. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*